News

The latest on managing care, value-based care, insurance markets, payers & providers

Three-tier drug copayments in; closed formularies on way out?

Three-tier prescription copayment designs are surging in popularity, according to an analysis by Scott-Levin. As of last fall, two thirds of health plans that offered a prescription benefit had instituted so-called triple copayments. By comparison, 12 months earlier, barely more than half of those plans had three-tier systems in place.

The copayments themselves are creeping up in price. The average copayment rose between 7 and 11 percent, depending on the tier, from spring of last year to fall.

Increasingly, health plans are placing brand-name drugs that are not on their formularies on the third tier, as opposed to placing only some nonpreferred brands and saying no to coverage of others. More than half of HMOs and pharmacy benefit managers do not charge the higher copayment for nonpreferred drugs if the product is deemed medically necessary.

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.